SOUTH KOREA · OPENDART
Orum Therapeutics, Inc.
오름테라퓨틱 · 475830 · KOSDAQ · Healthcare · Biotechnology
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
Other changes in holdings · 9
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2026-06-01 | Peter Unnam Park | Non-executive director | Stock options(+) | 100,000 | DART ↗ |
| 2026-06-01 | Kim Byungwoo | Auditor | Stock options(+) | 3,300 | DART ↗ |
| 2025-12-01 | InterVest Co., Ltd. | 10% shareholder | Disposal in exchange(-) | 85,000 | DART ↗ |
| 2025-11-28 | InterVest Co., Ltd. | 10% shareholder | Disposal in exchange(-) | 150,000 | DART ↗ |
| 2025-11-27 | InterVest Co., Ltd. | 10% shareholder | Disposal in exchange(-) | 87,665 | DART ↗ |
| 2025-02-14 | Jeong In Tae | Director | New listing(+) | 10,000 | DART ↗ |
| 2025-02-14 | Peter Unnam Park | Non-executive director | New listing(+) | 60,000 | DART ↗ |
| 2025-02-14 | Lee Sung Joo | CEO | New listing(+) | 3,388,000 | DART ↗ |
| 2025-02-14 | InterVest Co., Ltd. | 10% shareholder | New listing(+) | 2,262,707 | DART ↗ |